Gene therapy offers new hope for children with metachromatic leukodystrophy.
dc.contributor.author | Kurtzberg, Joanne | |
dc.date.accessioned | 2022-03-23T14:27:10Z | |
dc.date.available | 2022-03-23T14:27:10Z | |
dc.date.issued | 2022-01 | |
dc.date.updated | 2022-03-23T14:27:10Z | |
dc.identifier | S0140-6736(22)00057-5 | |
dc.identifier.issn | 0140-6736 | |
dc.identifier.issn | 1474-547X | |
dc.identifier.uri | ||
dc.language | eng | |
dc.publisher | Elsevier BV | |
dc.relation.ispartof | Lancet (London, England) | |
dc.relation.isversionof | 10.1016/s0140-6736(22)00057-5 | |
dc.subject | Humans | |
dc.subject | Leukodystrophy, Metachromatic | |
dc.subject | Hematopoietic Stem Cell Transplantation | |
dc.subject | Child | |
dc.subject | Genetic Therapy | |
dc.title | Gene therapy offers new hope for children with metachromatic leukodystrophy. | |
dc.type | Journal article | |
duke.contributor.orcid | Kurtzberg, Joanne|0000-0002-3370-0703 | |
pubs.begin-page | 338 | |
pubs.end-page | 339 | |
pubs.issue | 10322 | |
pubs.organisational-group | Duke | |
pubs.organisational-group | School of Medicine | |
pubs.organisational-group | Clinical Science Departments | |
pubs.organisational-group | Institutes and Centers | |
pubs.organisational-group | Pathology | |
pubs.organisational-group | Pediatrics | |
pubs.organisational-group | Duke Cancer Institute | |
pubs.organisational-group | Institutes and Provost's Academic Units | |
pubs.organisational-group | Initiatives | |
pubs.organisational-group | Duke Innovation & Entrepreneurship | |
pubs.organisational-group | Pediatrics, Transplant and Cellular Therapy | |
pubs.publication-status | Published | |
pubs.volume | 399 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- p391 Kurtzberg.pdf
- Size:
- 302.5 KB
- Format:
- Adobe Portable Document Format
- Description:
- Published version